It is also important to point out that a number of other studies published in recent months have raised questions about the efficacy, cost effectiveness, and safety of other types of robotic procedures.
New York, New York (PRWEB) November 05, 2013
As da Vinci robot lawsuit (http://www.badrobotsurgery.us/) filings continue to mount in courts around the country, Bernstein Liebhard LLP notes Intuitive Surgical, Inc., the maker of the da Vinci Surgical System, is touting a newly published study that finds benefits in the use of robotic surgery to remove diseased lung tissue. According to a report from MassDevice.com, Intuitive Surgical announced the results of the study on November 4th, proclaiming that it had found that robotic procedures resulted in lower death rates, shorter hospital stays and fewer complications compared to open procedures.*
“As MassDevice.com points out, the research only compares robotic surgery to open procedures, and its benefits over laparoscopic surgery are still open for debate. It is also important to point out that a number of other studies published in recent months have raised questions about the efficacy, cost effectiveness, and safety of other types of robotic procedures. The fact remains that the overall benefits and risks of robotic surgery still need further evaluation,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm is currently offering free da Vinci lawsuit evaluations to anyone who may have suffered serious injuries, including surgical burns, torn blood vessels, and organ perforations, in procedures involving the da Vinci Surgical System.
Da Vinci Robot Lawsuits
Intuitive Surgical disclosed last month that it is now named in at least 50 da Vinci lawsuits, all of which allege serious, and in some cases, fatal injuries due to the da Vinci Surgical System. The company also stated that it had reached tolling agreements to suspend the statute of limitations in certain cases, stating they were intended to provide “the parties and their legal counsel with additional time to evaluate the claims, and to explore whether the claims have merit and whether they can be resolved without litigation.”** (Cook v. Intuitive Surgical Inc., No. 12-6363 (N.D. Calif.))
Over the past year, a number of studies have raised questions about the safety and efficacy of robotic surgery. For example, Bloomberg.com reported in September that research published in Obstetrics & Gynecology found that robotic hysterectomy is not associated with reduced rates of complications, and may even double a patient’s risk of developing pneumonia.*** In August, a study published in the Journal of Healthcare Quality suggested that da Vinci complications may be underreported to the U.S. Food & Drug Administration (FDA).**** In February, a study published in the Journal of the American Medical Association reported that the costs associated with robotic surgery hysterectomy was more expensive compared to other methods, with little difference in complication rates.*****
In July, the FDA issued a warning letter to Intuitive Surgical after agency inspectors determined the company hadn’t adequately reported device corrections and patient adverse events in some cases. Most recently, Bloomberg.com revealed that reports of robotic surgery complications had doubled in the first eight months of this year, compared with the same period last year. ******
Individuals who suffered surgical burns, torn blood vessels, organ perforation, or other serious complications allegedly due to the da Vinci Surgical System may be entitled to compensation for medical bills, lost wages, pain and suffering, and other damages. Learn More about potential robotic surgery complications at Bernstein Liebhard LLP’s website. For a free, no-obligation case review, please call 800-511-5092.
**sec.gov/Archives/edgar/data/1035267/000103526713000040/isrg-2013930x10q.htm, Intuitive Surgical SEC Filing, October 18, 2013
***bloomberg.com/news/2013-09-09/no-safety-benefit-found-in-use-of-robot-for-hysterectomy.html, Bloomberg.com, September 9, 2013
****onlinelibrary.wiley.com/doi/10.1111/jhq.12036/abstract, Journal of Healthcare Quality, August 27, 2013
*****jama.jamanetwork.com/article.aspx?articleid=1653522; JAMA, February 20, 2013
******bloomberg.com/news/2013-10-08/robot-surgery-damaging-patients-rises-with-marketing.html, Bloomberg.com, October 8, 2013
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 11 consecutive years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com